Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Pavone-Macaluso

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
International Urology and Nephrology|May 19, 2009
Editorial commentMichele Pavone-Macaluso
European Urology|February 2, 2008
Words of wisdom. Re: the role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomyMichele Pavone-Macaluso
European Urology|September 17, 2010
Words of wisdom. Re: Does oral antiandrogen use before leuteinizing hormone-releasing therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare? Oh WK, Landrum MB, Lamont EB, et al. Urology 2010;75:642-7Michele Pavone-Macaluso
European Urology|March 24, 2004
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvisAntonio Lopez-Beltran, PierFrancesco Bassi, Michele Pavone-Macaluso, et al.
BJU International|October 30, 2010
Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)Renzo Colombo, Andrea Salonia, Zvi Leib, et al.
Urology|January 26, 2005
Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesionsVincenzo Serretta, Antonino Galuffo, Carlo Pavone, et al.
Virchows Archiv : an International Journal of Pathology|June 9, 2004
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working GroupAntonio Lopez-Beltran, Pier Francesco Bassi, Michele Pavone-Macaluso, et al.
BJU International|August 2, 2006
The pathology of bladder cancer: An update on selected issuesMichele Pavone-Macaluso, Antonio Lopez-Beltran, Federico Aragona, et al.
European Urology|May 20, 2004
TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 yearsVincenzo Serretta, Carlo Pavone, Giovan Battista Ingargiola, et al.
Anticancer Research|January 18, 2003
Does P-glycoprotein-170 expression predict for chemoresistance in transitional cell carcinoma of the bladder?Rosario Sanguedolce, Anna Calascibetta, Rossana Porcasi, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Urology and Nephrology|May 19, 2009
Editorial commentMichele Pavone-Macaluso
European Urology|February 2, 2008
Words of wisdom. Re: the role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomyMichele Pavone-Macaluso
European Urology|September 17, 2010
Words of wisdom. Re: Does oral antiandrogen use before leuteinizing hormone-releasing therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare? Oh WK, Landrum MB, Lamont EB, et al. Urology 2010;75:642-7Michele Pavone-Macaluso
European Urology|March 24, 2004
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvisAntonio Lopez-Beltran, PierFrancesco Bassi, Michele Pavone-Macaluso, et al.
BJU International|October 30, 2010
Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)Renzo Colombo, Andrea Salonia, Zvi Leib, et al.
Urology|January 26, 2005
Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesionsVincenzo Serretta, Antonino Galuffo, Carlo Pavone, et al.
Virchows Archiv : an International Journal of Pathology|June 9, 2004
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working GroupAntonio Lopez-Beltran, Pier Francesco Bassi, Michele Pavone-Macaluso, et al.
BJU International|August 2, 2006
The pathology of bladder cancer: An update on selected issuesMichele Pavone-Macaluso, Antonio Lopez-Beltran, Federico Aragona, et al.
European Urology|May 20, 2004
TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 yearsVincenzo Serretta, Carlo Pavone, Giovan Battista Ingargiola, et al.
Anticancer Research|January 18, 2003
Does P-glycoprotein-170 expression predict for chemoresistance in transitional cell carcinoma of the bladder?Rosario Sanguedolce, Anna Calascibetta, Rossana Porcasi, et al.
Pageof 2